Arena Pharma Reveals Positive Results From Phase Ib Clinical Trial

Arena Pharmaceuticals announced positive results from a multiple-ascending dose Phase 1b clinical trial of APD791 evaluating its safety, pharmacokinetics and pharmacodynamics. APD791 is Arena’s internally discovered oral drug candidate intended for the treatment of arterial thrombosis and other related conditions. 
RTTNews